Healthcare provider profile · identity verified

Susan M Wolf, CRNP

Nurse Practitioner · OXFORD, PA · NPI 1245230499

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	200
Omeprazole	Omeprazole	304	104
Lisinopril	Lisinopril	286	106
Levothyroxine Sodium	Levothyroxine Sodium	284	82
Amlodipine Besylate	Amlodipine Besylate	255	98
Metoprolol Succinate	Metoprolol Succinate	228	84
Rosuvastatin Calcium	Rosuvastatin Calcium	215	82
Gabapentin	Gabapentin	161	66
Pantoprazole Sodium	Pantoprazole Sodium	138	49
Eliquis	Apixaban	133	32
Losartan Potassium	Losartan Potassium	114	43
Duloxetine Hcl	Duloxetine Hcl	113	39
Furosemide	Furosemide	110	41
Escitalopram Oxalate	Escitalopram Oxalate	109	37
Albuterol Sulfate Hfa	Albuterol Sulfate	104	50
Metformin Hcl Er	Metformin Hcl	101	35
Sertraline Hcl	Sertraline Hcl	84	31
Fluticasone Propionate	Fluticasone Propionate	83	41
Metformin Hcl	Metformin Hcl	82	36
Montelukast Sodium	Montelukast Sodium	75	29
Tramadol Hcl	Tramadol Hcl	75	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	14
Valsartan	Valsartan	74	22
Tamsulosin Hcl	Tamsulosin Hcl	73	29
Jardiance	Empagliflozin	72	26
Simvastatin	Simvastatin	72	27
Buspirone Hcl	Buspirone Hcl	71	25
Ozempic	Semaglutide	71	21
Hydrochlorothiazide	Hydrochlorothiazide	67	29
Alprazolam	Alprazolam	65	24
Famotidine	Famotidine	63	20
Allopurinol	Allopurinol	62	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	31
Oxycodone Hcl	Oxycodone Hcl	59	14
Tizanidine Hcl	Tizanidine Hcl	59	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	20
Lorazepam	Lorazepam	57	15
Zolpidem Tartrate	Zolpidem Tartrate	57	20
Trazodone Hcl	Trazodone Hcl	56	22
Trulicity	Dulaglutide	55	suppressed
Mirtazapine	Mirtazapine	53	18
Clopidogrel	Clopidogrel Bisulfate	51	14
Metoprolol Tartrate	Metoprolol Tartrate	51	25
Pravastatin Sodium	Pravastatin Sodium	51	19
Ezetimibe	Ezetimibe	50	15
Citalopram Hbr	Citalopram Hydrobromide	47	16
Quetiapine Fumarate	Quetiapine Fumarate	47	11
Spironolactone	Spironolactone	47	18
Fluoxetine Hcl	Fluoxetine Hcl	44	16
Bupropion Xl	Bupropion Hcl	42	16
Carvedilol	Carvedilol	42	13
Potassium Chloride	Potassium Chloride	42	11
Finasteride	Finasteride	40	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	11
Doxycycline Hyclate	Doxycycline Hyclate	39	35
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Glimepiride	Glimepiride	34	12
Mounjaro	Tirzepatide	33	suppressed
Prednisone	Prednisone	33	30
Diclofenac Sodium	Diclofenac Sodium	32	15
Pioglitazone Hcl	Pioglitazone Hcl	31	11
Venlafaxine Hcl Er	Venlafaxine Hcl	31	13
Xarelto	Rivaroxaban	31	suppressed
Irbesartan	Irbesartan	30	12
Alendronate Sodium	Alendronate Sodium	29	suppressed
Celecoxib	Celecoxib	28	16
Pregabalin	Pregabalin	28	18
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Synthroid	Levothyroxine Sodium	26	11
Atenolol	Atenolol	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	20
Baclofen	Baclofen	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Naproxen	Naproxen	20	suppressed
Nystatin	Nystatin	20	11
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Haloperidol	Haloperidol	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Cephalexin	Cephalexin	16	16
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error